Literature DB >> 15603857

Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis.

Sarah Burdett1, Lesley Stewart.   

Abstract

We report an updated systematic review and individual patient data meta-analysis of the effectiveness of postoperative radiotherapy (PORT) in non-small-cell lung cancer. Results continue to show PORT to be detrimental, with an 18% relative increase in the risk of death. Similar detriments were observed for local recurrence-free survival, distant recurrence-free survival and overall recurrence-free survival. There continues to be evidence that the effects of PORT are more harmful in those patients with stage I disease than those with stage II disease.

Entities:  

Mesh：

Year:  2005        PMID： 15603857     DOI： 10.1016/j.lungcan.2004.09.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


  32 in total

1.  Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.

Authors:  Rajwanth R Veluswamy; Grace Mhango; Marcelo Bonomi; Alfred I Neugut; Dawn L Hershman; Melissa D Aldridge; Juan P Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2013-12

2.  Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data.

Authors:  Mark R Green; Michele Andrews; Richard Leff; Joanne Willey; Carmen Allegra; Alex Denes; James Epstein; James Jones; Lee Lokey
Journal:  J Oncol Pract       Date:  2005-07       Impact factor: 3.840

Review 3.  Lung Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

4.  Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.

Authors:  M Majem; J Hernández-Hernández; F Hernando-Trancho; N Rodríguez de Dios; A Sotoca; J C Trujillo-Reyes; I Vollmer; R Delgado-Bolton; M Provencio
Journal:  Clin Transl Oncol       Date:  2019-06-06       Impact factor: 3.405

Review 5.  Advances in adjuvant systemic therapy for non-small-cell lung cancer.

Authors:  David Leong; Rajat Rai; Brandon Nguyen; Andrew Lee; Desmond Yip
Journal:  World J Clin Oncol       Date:  2014-10-10

6.  Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.

Authors:  Zuen Ren; Shijie Zhou; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

7.  Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review.

Authors:  M Smoragiewicz; J Laskin; D Wilson; K Ramsden; J Yee; S Lam; T Shaipanich; Y Zhai; C Ho
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

Review 8.  Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).

Authors:  A Gómez; J A González; F Couñago; C Vallejo; F Casas; N Rodríguez de Dios
Journal:  Clin Transl Oncol       Date:  2015-08-18       Impact factor: 3.405

Review 9.  UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.

Authors:  Fumihiro Tanaka
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

Review 10.  Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.

Authors:  Yelena Krupitskaya; Billy W Loo
Journal:  Curr Treat Options Oncol       Date:  2009-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.